Skip to main content

Advertisement

Log in

Time to surgery and complications in hip fracture patients on novel oral anticoagulants: a systematic review

  • Trauma Surgery
  • Published:
Archives of Orthopaedic and Trauma Surgery Aims and scope Submit manuscript

Abstract

Background

Early surgery has been consistently demonstrated to reduce complications and mortality in hip fracture patients. There remains no general consensus, however, regarding the optimal time to surgery for hip fracture patients who are on novel oral anticoagulants (NOAC) on admission and its effect on clinical outcomes after surgery. The objective of this review was to assess the effect of preoperative NOAC therapy on time to surgery and postoperative complications in hip fracture patients.

Methods

We performed a systematic review of the literature using the PubMed, Embase, and Cochrane Library electronic databases. Relevant articles were identified and included if they: (i) included patients on NOAC therapy on admission who did not undergo reversal; (ii) included a control group of patients not on any anticoagulation; (iii) included time from admission to surgery; and (iv) included one of the following outcomes: blood transfusion, venous thromboembolism (VTE), stroke, readmission, and mortality.

Results

Nine studies were included with a total of 4,419 patients. There were 414 NOAC patients and 4,005 non-anticoagulated patients. Six of the nine studies found a significant increase in time to surgery for patients on NOAC therapy. Three of the seven studies that reported rates of blood transfusion found a significantly higher incidence of transfusion in patients on NOACs. None of the studies found a significant difference in VTE and stroke. One of the two studies that reported readmissions showed a higher risk of readmission for patients on NOACs. Eight of the nine included studies found no significant difference in postoperative mortality rates between the NOAC and control groups, with the remaining study finding a higher mortality rate only in patients on NOAC therapy who underwent fixation and not those who underwent arthroplasty.

Conclusions

These mixed findings suggest that delay to surgery may not be warranted in the urgent surgical setting of patients on NOAC therapy who sustain hip fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7(5):407–413

    Article  CAS  Google Scholar 

  2. Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ (2002) Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 50(10):1644–1650

    Article  Google Scholar 

  3. Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103(2A):12S-17S

    Article  CAS  Google Scholar 

  4. Ftouh S, Morga A, Swift C, Guideline Development Group (2011) Management of hip fracture in adults: summary of NICE guidance. BMJ. https://doi.org/10.1136/bmj.d3304

    Article  Google Scholar 

  5. Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ (2009) Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury 40(7):692–697

    Article  Google Scholar 

  6. Ryan DJ, Yoshihara H, Yoneoka D, Egol KA, Zuckerman JD (2015) Delay in hip fracture surgery: an analysis of patient-specific and hospital-specific risk factors. J Orthop Trauma 29(8):343–348

    Article  Google Scholar 

  7. Lawrence JE, Fountain DM, Cundall-Curry DJ, Carrothers AD (2017) Do patients taking warfarin experience delays to theatre, longer hospital stay, and poorer survival after hip fracture? Clin Orthop Relat Res 475(1):273–279

    Article  Google Scholar 

  8. Tran T, Delluc A, de Wit C, Petrcich W, Le Gal G, Carrier M (2015) The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture. Thromb Res 136(5):962–965

    Article  CAS  Google Scholar 

  9. Barnes GD, Lucas E, Alexander GC, Goldberger ZD (2015) National trends in ambulatory oral anticoagulant use. Am J Med 128(12):1300–1305

    Article  Google Scholar 

  10. Collinge CA, Kelly KC, Little B, Weaver T, Schuster RD (2012) The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery. J Orthop Trauma 26(10):568–573

    Article  Google Scholar 

  11. Franklin NA, Ali AH, Hurley RK, Mir HR, Beltran MJ (2018) Outcomes of early surgical intervention in geriatric proximal femur fractures among patients receiving direct oral anticoagulation. J Orthop Trauma 32(6):269–273

    Article  Google Scholar 

  12. Mullins B, Akehurst H, Slattery D, Chesser T (2018) Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre. BMJ Open 8(4):e020625

    Article  Google Scholar 

  13. Frenkel Rutenberg T, Velkes S, Vitenberg M, Leader A, Halavy Y, Raanani P et al (2018) Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants. Thromb Res 166:106–112

    Article  CAS  Google Scholar 

  14. Bruckbauer M, Prexl O, Voelckel W, Ziegler B, Grottke O, Maegele M et al (2019) Impact of direct oral anticoagulants in patients with hip fractures. J Orthop Trauma 33(1):e8-13

    Article  Google Scholar 

  15. Schermann H, Gurel R, Gold A, Maman E, Dolkart O, Steinberg EL et al (2019) Safety of urgent hip fracture surgery protocol under influence of direct oral anticoagulation medications. Injury 50(2):398–402

    Article  Google Scholar 

  16. Hourston GJ, Barrett MP, Khan WS, Vindlacheruvu M, McDonnell SM (2019) New drug, new problem: do hip fracture patients taking NOACs experience delayed surgery, longer hospital stay, or poorer outcomes? Hip Int 25:1120700019841351

    Google Scholar 

  17. Schuetze K, Eickhoff A, Dehner C, Gebhard F, Richter PH (2019) Impact of oral anticoagulation on proximal femur fractures treated within 24h—a retrospective chart review. Injury 50(11):2040–2044

    Article  CAS  Google Scholar 

  18. Cafaro T, Simard C, Tagalakis V, Koolian M, Network CanVECTOR (2019) Delayed time to emergency hip surgery in patients taking oral anticoagulants. Thromb Res 184:110–114

    Article  CAS  Google Scholar 

  19. Cohn MR, Levack AE, Trivedi NN, Villa JC, Wellman DS, Lyden JP et al (2017) The hip fracture patient on warfarin: evaluating blood loss and time to surgery. J Orthop Trauma 31(8):407–413

    Article  Google Scholar 

  20. Martin DT, Barton CA, Dodgion C, Schreiber M (2016) Emergent reversal of vitamin K antagonists: addressing all the factors. Am J Surg 211(5):919–925

    Article  Google Scholar 

  21. Mattisson L, Lapidus LJ, Enocson A (2018) Is fast reversal and early surgery (within 24 h) in patients on warfarin medication with trochanteric hip fractures safe? A case-control study. BMC Musculoskelet Disord 19(1):203

    Article  Google Scholar 

  22. Moores TS, Chatterton BD, Walker MJ, Roberts PJ (2018) Standardised warfarin reversal expedites time to theatre for fractured neck of femur surgery and improves mortality rates: a matched cohort study. Adv Orthop 21:4791214

    Google Scholar 

  23. Meinig R, Jarvis S, Orlando A, Nwafo N, Banerjee R, McNair P et al (2020) Is anticoagulation reversal necessary prior to surgical treatment of geriatric hip fractures? J Clin Orthop Trauma 11(Suppl 1):S93–S99

    Article  Google Scholar 

  24. Yoo MS, Zhu S, Jiang SF, Hammer HL, McBride WJ, McCarthy CM et al (2020) Association of reversal of anticoagulation preoperatively on 30-day mortality and outcomes for hip fracture surgery. Am J Med. https://doi.org/10.1016/j.amjmed.2020.01.002

    Article  PubMed  Google Scholar 

  25. Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott EM et al (2019) Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol 94(6):697–709

    Article  Google Scholar 

  26. Caruso G, Andreotti M, Marko T, Tonon F, Corradi N, Rizzalo D et al (2019) The impact of warfarin on operative delay and 1-year mortality in elderly patients hip hip fracture: a retrospective observational study. J Orthop Surg Res 14(1):169

    Article  Google Scholar 

Download references

Funding

There is no funding source.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zoe B. Cheung.

Ethics declarations

Conflict of interest

Dr. Forsh has financial relationships with Stryker (paid consultant). None of the other authors have any financial interests or affiliations with institutions, organizations, or companies relevant to the manuscript. None of the authors received payment or funding support in kind for any aspect of the submitted work.

Institutional Review Board Approval

IRB approval was not required for the submitted work at our institution.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheung, Z.B., Xiao, R. & Forsh, D.A. Time to surgery and complications in hip fracture patients on novel oral anticoagulants: a systematic review. Arch Orthop Trauma Surg 142, 633–640 (2022). https://doi.org/10.1007/s00402-020-03701-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00402-020-03701-2

Keywords

Navigation